Human Normal Immunoglobulin - Panzyga (CMU Call Off)
Details
- Supplier(s)
- Octapharma Ltd
- Value
- GBP 1,495,223
- Topic
- Immunoglobulins
- Published
- 5 October 2021
Tender description
NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.
Timeline
- Completed: Award date10 June 2021
- Completed: Award published5 October 2021Current notice
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33651520 · Immunoglobulins
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
Related buyers
Buyers similar to NHS National Services Scotland.
- 19£4.6m
- 9£1.1m
- 6£445.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 745£1.9bn
- 231£2.0bn
- 136£1.4bn
- 126£60.5m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
